alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
# C_2019164EN.01004701.xml

| 13.5.2019 | EN | Official Journal of the European Union | C 164/47 |
| --- | --- | --- | --- |

13.5.2019

EN

Official Journal of the European Union

C 164/47

---

Judgment of the General Court of 27 March 2019 — Biernacka-Hoba v EUIPO — Formata Bogusław Hoba (Formata)

(Case T-265/18) (1)

(EU trade mark - Invalidity proceedings - EU figurative mark Formata - Earlier international figurative mark Formata - Relative ground for invalidity - Article 60(1)(a) and Article 8(1)(a) and (b) of Regulation (EU) 2017/1001 - Rule 37 of Regulation (EC) No 2868/95 (now Article 12 of Delegated Regulation (EU) 2018/625) - Conditions governing the representation of the earlier mark - Rule 19 of Regulation No 2868/95 (now Article 7 of Delegated Regulation 2018/625) - Legitimate expectations - Reimbursement of the costs of representation - Article 109 of Regulation 2017/1001 and Rule 94 of Regulation No 2868/95 (now Article 109 of Regulation 2017/1001))

(2019/C 164/50)

Language of the case: Polish

Parties

Applicant: Illona Biernacka-Hoba (Aleksandrów Łódzki, Poland) (represented by: R. Rumpel, lawyer)

Defendant: European Union Intellectual Property Office (represented by: D. Walicka, acting as Agent)

Other party to the proceedings before the Board of Appeal of EUIPO: Formata Bogusław Hoba (Aleksandrów Łódzki, Poland)

Re:

Action brought against the decision of the Fourth Board of Appeal of EUIPO of 13 February 2018 (Case R 2032/2017-4), relating to invalidity proceedings between Ms Biernacka-Hoba and Formata Bogusław Hoba

Operative part of the judgment

The Court:

| 1. | Annuls the decision of the Fourth Board of Appeal of the European Union Intellectual Property Office (EUIPO) of 13 February 2018 (Case R 2032/2017-4), in so far as it ordered Ms Ilona Biernacka-Hoba to pay the costs incurred by Formata Bogusław Hoba for the purposes of the invalidity proceedings and the appeal and fixed the amount of the costs that Ms Biernacka-Hoba had to pay to Formata Bogusław Hoba at EUR 1000, and alters that decision to the effect that Ms Biernacka-Hoba must not be ordered to pay such a sum; |
| --- | --- |

1.

Annuls the decision of the Fourth Board of Appeal of the European Union Intellectual Property Office (EUIPO) of 13 February 2018 (Case R 2032/2017-4), in so far as it ordered Ms Ilona Biernacka-Hoba to pay the costs incurred by Formata Bogusław Hoba for the purposes of the invalidity proceedings and the appeal and fixed the amount of the costs that Ms Biernacka-Hoba had to pay to Formata Bogusław Hoba at EUR 1000, and alters that decision to the effect that Ms Biernacka-Hoba must not be ordered to pay such a sum;

| 2. | Dismisses the action as to the remainder; |
| --- | --- |

2.

Dismisses the action as to the remainder;

| 3. | Orders each party to bear its own costs. |
| --- | --- |

3.

Orders each party to bear its own costs.

---

(1)  OJ C 231, 2.7.2018.

---
Exhibit 32.2

            CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER
                 PURSUANT TO 18 U.S.C. SECTION 1350
                 AS ADOPTED PURSUANT TO SECTION 906
                 OF THE SARBANES-OXLEY  ACT OF 2002

     In connection with the Annual Report on Form 10-K of Financial
Federal Corporation (the "Company") for the year ended July 31,
2008, as filed with the Securities and Exhange Commission (the
"Report"), Steven F. Groth, Chief Financial Officer of the Company,
hereby certifies pursuant to 18 U.S.C. Section 1350, as adopted
pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to
his knowledge:

     (1) the Report fully complies with the requirements of Section
     13(a) or 15(d) of the Securities Exchange Act of 1934; and

     (2) the information contained in the Report fairly presents, in
     all material respects, the financial condition and results of
     operations of the Company

     A signed original of this written statement required by section
906 has been provided to the Company and will be retained by the
Company and furnished to the Securities and Exchange Commission or its
staff upon request.



September 24, 2008                /s/ Steven F. Groth
------------------                ----------------------------------
Date                              Steven F. Groth
                                  Chief Financial Officer and Senior
                                  Vice President
Eligibility Requirements for a New Establishment to Submit Via the NCAH Portal 

While the NCAH Portal is a valuable tool for both submitters and the CVB, CVB resources are expended to 

establish portal accounts, teach proper submission procedures, and to provide technical support to new 

establishments. The CVB receives numerous inquiries from new establishments each year, but only a subset of those 

proceed beyond the initial inquiry. 

For this reason, initial submissions from new establishments must be submitted on paper. 

When the following criteria have been met, NCAH Portal access may be requested from the CVB - see link in step 6 

below.

Product being proposed by the new establishmentis confirmed to be under the regulatory jurisdiction of 

the CVB

Product is suitable for licensure/permitting. Considerationsinclude, but are not limited to:

Product intended for a disease for which the CVB currently issues licenses/permits

Acceptable (negligible) risk associated with ingredients of animal origin

Facility requirements are likely to be met

• Production facilities(even though not necessarily inspected yet) are reasonably expected to be acceptable

• An acceptable U.S. Permittee and quarantine site has been identified for imported products

• Facility documents must be submitted to CVB. See VS Memo 800.78 for guidance. 

A USDA Establishment Code has been assigned by the CVB

All proposed portal users have read the CVB user guides for proper portal use. Supplemental 

training videos are also available. The training materials discuss not only technical procedures, but 

also CVB business rules for acceptable submissions. After reading the guidance, a teleconference 

with CVB is strongly encouraged to ensure understanding and to answer any remaining questions 

prior to submitting via portal.

Follow the step-by-step instructionsfor NCAH Portal access to request accessto the NCAH Portal 













•

•

12/27/2019
Letter of Resignation


 




EXHIBIT 10.18




To:

Paymeon Board of Directors

From:

Edward A. Cespedes

Date:

April 13, 2018




Gentlemen:

Effective immediately I hereby resign all my positions at Paymeon, Inc. and its affiliated companies.  I will assist with any transition necessary and retain all rights under my employment agreement and any other rights afforded me in terms of indemnity from the Company.

Respectfully,




Edward A. Cespedes
# C_2018436EN.01001701.xml

| 3.12.2018 | EN | Official Journal of the European Union | C 436/17 |
| --- | --- | --- | --- |

3.12.2018

EN

Official Journal of the European Union

C 436/17

---

Request for a preliminary ruling from the Tribunale Amministrativo Regionale per la Sardegna (Italy) lodged on 6 August 2018 — Autorità Garante della Concorrenza e del Mercato v Regione autonoma della Sardegna

(Case C-515/18)

(2018/C 436/22)

Language of the case: Italian

Referring court

Tribunale Amministrativo Regionale per la Sardegna

Parties to the main proceedings

Applicant: Autorità Garante della Concorrenza e del Mercato

Defendant: Regione autonoma della Sardegna

Questions referred

| 1. | Must Article 7(2) of Regulation (EC) No 1370/2007 (1) of 23 October 2007 be interpreted as meaning that the competent authority which intends directly to award a contract must take the necessary steps to publish or communicate to all operators potentially interested in operating the service the information necessary to allow such operators to submit a serious and reasonable offer? |
| --- | --- |

1.

Must Article 7(2) of Regulation (EC) No 1370/2007 (1) of 23 October 2007 be interpreted as meaning that the competent authority which intends directly to award a contract must take the necessary steps to publish or communicate to all operators potentially interested in operating the service the information necessary to allow such operators to submit a serious and reasonable offer?

| 2. | Must Article 7(4) of Regulation (EC) No 1370/2007 of 23 October 2007 be interpreted as meaning that, before directly awarding the contract, the competent authority must carry out a comparative assessment of all bids to operate the service which may have been received following publication of the prior information notice under that Article 7(4)? |
| --- | --- |

2.

Must Article 7(4) of Regulation (EC) No 1370/2007 of 23 October 2007 be interpreted as meaning that, before directly awarding the contract, the competent authority must carry out a comparative assessment of all bids to operate the service which may have been received following publication of the prior information notice under that Article 7(4)?

---

(1)  Regulation (EC) No 1370/2007 of the European Parliament and of the Council of 23 October 2007 on public passenger transport services by rail and by road and repealing Council Regulations (EEC) Nos 1191/69 and 1107/70 (OJ 2007 L 315, p. 1).

---
T hi s di s pos i t i on i s notappr opr i a t e f orpubl i c a t i on and i s notpr e c e de nt * e xc e pta s pr ovi de d by9th C i r . R . 36- 3.

T he pane l unani m ous l yc onc l ude s thi s c a s e i s s ui t abl e f orde c i s i on ** w ith o u t o r a l ar g u m e n t. See F ed. R . A pp . P . 34 (a )( 2). NOT F OR P UB L I CAT I ON UN I TE D STATE S C OU RT OF APPE ALS FOR T HE NI NTH CI RC UI T J OS E MAR I A R OB L E DO ME Z A, P et i t i on er , v. E R I C H . H O L D E R , J r ., A tto rn e yG e n e r a l, R e s p o n d e n t. N o. 08- 72251 A ge nc yN o. A 037- 732- 564 ME MOR AN DU M *

O n P e t i t i on f

orR e vi e w of

an O r de rof

the B o ar do f I m m ig r a tio n A p p e a ls S ubm i tt e d N ove m be r16, 2010 ** B e f o r e : T A S H I M A , B E R Z O N , an dC L I F T O N , C ir c u it Ju d g e s . J os e M ar i aR obl e do M e z a , ana t i ve and c i t i z e n of M e xi c o, pe t i t i ons f

or re vi ew of the B oard of Im m i grat i on A pp ea l s’ order di sm i ss i ng hi s app ea l fr om an i m m i gr a t i on j udge ’ s ( “ I J ” ) r e m ova l or de r . O urj ur i s di c t i on i s gove rne d by 8 U .S .C . § 1 2 5 2 . W e r e v ie w d e n o v o c o n s titu tio n a l c la im s , Kha n v. H older , 584 

# FI LED NO V 30 2010 M OLLY C. DW Y ER, CLERK U . S. C O U R T OF APPE ALS08- 72251 2 F . 3d 773, 776 ( 9th C i r . 2009) , and w e di s m i s s i n partand de nyi n partthe pe t i t i on f o rr e v ie w . W e l ac k j uri sdi ct i on t o revi ew the agency’ s di sc re t i on ary deni alof re l i ef u n d e rf o rme rs e c t i o n 2 1 2 ( c ) o f th e I mmi g r a t i o n an dN a t i o n a l i tyA c t , 8 U . S. C. § 1 1 8 2 ( c ) ( r e p e a le d1 9 9 6 ) . See 8 U . S . C . § 1 25 2(a) (2)( B )( i i ); V arga s-H erna ndezv. G on zales , 4 9 7 F .3 d9 1 9 , 9 2 3 ( 9 th C ir . 2 0 0 7 ) . R obl e do M e z a ’ s c ont e nt i on tha tthe I Jr e f us e d t o a l l ow R obl e do M e z aand h is w itn e s s e s to te s tif

yis n o t s up p o rte db yth e r e c o r d . Se e La ta v . I NS , 204 F . 3d 12 41 , 12 46 (9th C i r. 20 00 ) ( re qu i ri ng error t o est abl i sh a due process vi ol at i on ). R obl e do M e z a ’ s s ubs t ant i ve due pr oc e s s c l a i m f a i l s be c aus e he ha s not a lle g e dth e p r e c is e te rm s o f an yp r o m is e m a d e to h im b yth e g o v e rn m e n t. See Morga n v. G on zales , 49 5 F . 3d 10 84 , 10 91 (9th C i r. 20 07 ). P E T I T I O N F O R R E V I E W D I S M I S S E D in p a r t ; D E N I E D in p a r t .
1 

### Hall-Jordan, Luke

From: Frey, Nathan J. [Nathan_J._Frey@omb.eop.gov] Sent: Friday, March 15, 2013 4:44 PM To: Owens, Nicole Cc: Ferris, Lena; Chamberlin, JohnB; Hufford, Drusilla; Hall-Jordan, Luke; Donaldson, David Subject: HCFC rule Attachments: winmail.dat



### OMB has officially concluded its review under EO 12 866 and 13563 of the EPA final rule, Protection of Stratospheric Ozone: Adjustments to t he Allowance System for Controlling HCFC Production, Import, and Export for 2012-2014: RIN 2 060-AQ98.
May 25, 2006

27257

#### Shipman v. State

Affirmed
ex_118433.htm


 


AMENDMENT NO. 2 TO


Restricted Stock Unit Award Agreement 


 


 


Effective as of July 18, 2018, Steven G. Simonson, M.D. (“Participant”) and Windtree Therapeutics, Inc. (the “Company”) hereby agree to amend the Restricted Stock Unit (“RSU”) Award Agreement between them dated as of November 1, 2017 and the related notice of award (as it may have been previously amended, the “RSU Agreement”) to reflect the revisions set forth herein (“Amendment No. 2”). Capitalized terms used herein and not otherwise defined shall have the meanings ascribed to such terms in the RSU Agreement.


 


Notwithstanding anything to the contrary set forth in the RSU Agreement, or in Participant’s Employment Agreement, as amended, the vesting date for the RSU awarded to Participant effective November 1, 2017 is hereby changed from August 1, 2018 to October 1, 2018. The second vesting date for the balance of the RSU award shall remain unchanged.


 


Except as amended herein, the remaining terms and conditions of the RSU Agreement shall remain in full force and effect. This Amendment No. 2confirms an agreement between Participant and the Company with respect to the subject matter hereof and is a material part of the consideration stated in the RSU Agreement and mutual promises made in connection therewith. The parties have executed this Amendment No. 2 as of the day and date first set forth above.


 


 


	
			Windtree Therapeutics, Inc.

				 
	 	 
	 	 
	
			By:       /s/ Kathy Cole

				 
	
			Name:  Kathy Cole

				
			/s/ Steven G. Simonson, M.D.

			
	
			Title:    SVP, Human Resources

				
			Name: Steven G. Simonson, M.D.
<TABLE> <S> <C>


<ARTICLE> 5

<LEGEND>
The schedule contains summary financial information extracted from the
consolidated financial statements and is qualified in its entirety by reference
to such financial statements.
</LEGEND>

<MULTIPLIER> 1

       
<S>                                                 <C>
<PERIOD-TYPE>                                       6-MOS
<FISCAL-YEAR-END>                                   JUN-30-1999
<PERIOD-START>                                      JUL-01-1998
<PERIOD-END>                                        DEC-31-1998
<CASH>                                                1,006,424
<SECURITIES>                                         11,858,309
<RECEIVABLES>                                         6,430,369
<ALLOWANCES>                                          2,330,759
<INVENTORY>                                           2,535,163
<CURRENT-ASSETS>                                     20,460,889
<PP&E>                                                3,208,441
<DEPRECIATION>                                        1,973,694
<TOTAL-ASSETS>                                       22,861,098
<CURRENT-LIABILITIES>                                 2,358,952
<BONDS>                                                       0
<PREFERRED-MANDATORY>                                         0
<PREFERRED>                                                   0
<COMMON>                                                 58,652
<OTHER-SE>                                           19,457,192
<TOTAL-LIABILITY-AND-EQUITY>                         22,861,098
<SALES>                                              11,423,780
<TOTAL-REVENUES>                                     11,423,780
<CGS>                                                 5,807,852
<TOTAL-COSTS>                                        11,899,167
<OTHER-EXPENSES>                                              0
<LOSS-PROVISION>                                              0
<INTEREST-EXPENSE>                                       26,784
<INCOME-PRETAX>                                         244,958
<INCOME-TAX>                                             59,935
<INCOME-CONTINUING>                                           0
<DISCONTINUED>                                                0
<EXTRAORDINARY>                                               0
<CHANGES>                                                     0
<NET-INCOME>                                            185,023
<EPS-PRIMARY>                                               .03
<EPS-DILUTED>                                               .03
        


</TABLE>
#### State v. Smith

23823

11/29/2001

Denied
<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS FINANCIAL INFORMATION EXTRACTED FROM THE MARCH 31, 2000
FORM 10-Q AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL
STATEMENTS CONTAINED THEREIN.
</LEGEND>
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             JAN-01-2000
<PERIOD-END>                               MAR-31-2000
<CASH>                                           (110)
<SECURITIES>                                         0
<RECEIVABLES>                                   31,928
<ALLOWANCES>                                         0
<INVENTORY>                                     54,939
<CURRENT-ASSETS>                                93,616
<PP&E>                                          21,991
<DEPRECIATION>                                   1,194
<TOTAL-ASSETS>                                 200,295
<CURRENT-LIABILITIES>                           38,253
<BONDS>                                              0
<PREFERRED-MANDATORY>                           11,159
<PREFERRED>                                          0
<COMMON>                                            65
<OTHER-SE>                                      57,310
<TOTAL-LIABILITY-AND-EQUITY>                   200,295
<SALES>                                         34,406
<TOTAL-REVENUES>                                34,406
<CGS>                                           20,659
<TOTAL-COSTS>                                   20,659
<OTHER-EXPENSES>                                17,163
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                               2,964
<INCOME-PRETAX>                                (6,380)
<INCOME-TAX>                                   (1,185)
<INCOME-CONTINUING>                            (5,195)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   (5,195)
<EPS-BASIC>                                     (0.86)
<EPS-DILUTED>                                   (0.86)


</TABLE>
Johne's Disease

Pooling Methods

6/29/2020 1 of 1

LabName Website City Country

General Lab 

Phone LabEmail Direct PCR Solid media Liquid media

International 

Infectious Diseases Laboratory Farm Animal & 

Veterinary Public Health

http://www.agriculture.gov.au/animal-planthealth/animal/vet Camden Australia 02 9351 1616 richard.whittington@sydney.edu.au ------- ------- PASSED

NSW Department of Primary Industries - Laboratory 

Services

https://www.dpi.nsw.gov.au/aboutus/services/laboratory-services Menangle Australia 1800 675 623 laboratory.services@dpi.nsw.gov.au PASSED ------- -------

Animal Health Centre, BCMAL http://www.agf.gov.bc.ca/ahc/index.htm Abbotsford, B.C. Canada 604-556-3135 john.h.robinson@gov.bc.ca PASSED ------- -------

Barkema / De Buck Laboratory www.ucalgary.ca/bprg/debuck_lab Calgary, Alberta Canada 403-210-6311 jdebuck@ucalgary.ca PASSED ------- PASSED

Atlantic Veterinary College www.milkquality.ca Charlottetown PEI 902-566-0968 ngrobinson@upei.ca PASSED ------- -------

Laboratoire d'épidémiosurveillance animale du 

Québec www.mapaq.gouv.qc.ca

Saint-Hyacinthe, 

Quebec Canada 450-778-6542 sophie.beaulieu@mapaq.gouv.qc.ca PASSED ------- PASSED

Agri-Food and Biosciences Institute http://www.afbini.gov.uk Belfast Ireland 44 2 890525730 maria.guelbenzu@afbini.gov.uk PASSED ------- -------

University of Otago-Disease Research Laboratory, 

University of Otago www.drl.otago.ac.nz Dunedin, Otago New Zealand 643-479-7710 rory.obrien@otago.ac.nz PASSED ------- -------

Biobest Laboratories Ltd. www.biobest.co.uk

Nr Penicuik, 

Scotland United Kingdom

44 0 131440 

2628 Sarah.McCallum@biobest.co.uk PASSED ------- -------
Fourth Court of Appeals

San Antonio, Texas

April 8, 2016

No. 04-15-00688-CV

IN THE ESTATE OF CARLOS AGUILAR, DECEASED,

From the County Court at Law No 2, Webb County, Texas

Trial Court No. 2012-PB4-000048 L2

Honorable Jesus Garza, Judge Presiding

O R D E R

Appellant’s brief was originally due on February 29, 2016. Neither the brief nor a 

motion for extension of time was filed. Appellant is represented on appeal by Mr. Ryan Grant 

Anderson. On March 9, 2016, this court ordered Mr. Anderson file appellant’s brief no later than 

March 30, 2016. Our order cautioned Mr. Anderson that if he failed to file the brief by this date 

or failed to reasonably explain the reason for his failure to do so, this appeal would be dismissed 

for want of prosecution. TEX. R. APP. P. 38.8(a)(1). On March 31, 2015, Mr. Anderson filed a 

motion asking for a two-day extension of time to file the brief, and this court granted the 

extension to April 1, 2016. The brief has not been filed.

Accordingly, Mr. Anderson is hereby ORDERED to show cause in writing, no later than

April 18, 2016, why this appeal should not be dismissed for want of prosecution. See TEX. R.

APP. P. 38.8(a)(1); 42.3(b), (c). Failure to respond by April 18, 2016 will result in the dismissal 

of this appeal. TEX. R. APP. P. 38.8(a).

On April 5, 2016, appellee filed a motion for sanctions, asserting the appeal is frivolous 

and citing Mr. Anderson’s failure to file appellant’s brief. Appellee’s motion for sanctions is 

ORDERED HELD IN ABEYANCE.

The Clerk of this court shall cause a copy of this order to be served on Mr. Anderson by 

certified mail, return receipt requested, and by United States mail. 

_________________________________

Sandee Bryan Marion, Chief Justice

IN WITNESS WHEREOF, I have hereunto set my hand and affixed the seal of the said 

court on this 8th day of April, 2016.

___________________________________

Keith E. Hottle

Clerk of Court
EXHIBIT 32.1



GENAERA CORPORATION



CERTIFICATION OF

CHIEF EXECUTIVE OFFICER

PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002



In connection with the Quarterly Report of Genaera Corporation (the Company) on Form 10-Q for the period ended
September 30, 2005 as filed with the Securities and Exchange Commission on the date hereof (the Report), I, Roy C. Levitt, M.D., Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted
pursuant to section 906 of the Sarbanes-Oxley Act of 2002, that:



| | (1) | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and
| | --- | ---------------------------------------------------------------------------------------------------------------------------------



| | (2) | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
| | --- | ----------------------------------------------------------------------------------------------------------------------------------------------------



|                       
|-----------------------
|                       
|/s/    ROY C. LEVITT   
|Roy C. Levitt, M.D.    
|Chief Executive Officer
|November 9, 2005